Is your retirement plan actually built to last? Take a 20-second quiz to book a call with Kyle and Dane at DePaolo & May Strategic Wealth. They’ll give you an honest opinion on whether you’re on track. Click here to take the quiz and book a call.

Big Tech is having a rough morning. An EV giant's earnings miss, a search titan's spending shock, and a chip beat that got sold off anyway all point to the same conclusion: for the names that led this market, good is no longer good enough.

The money is going somewhere, though. Healthcare stocks are dominating the gainers list, led by a drug-delivery supplier's monster beat-and-raise, and a defense contractor's clean quarter is getting rewarded too.

Most portfolios are a pile of accounts, not a plan. DePaolo & May — a fee-only, fiduciary firm named a Top 25 Rising Star advisory firm by USA Today — will review your situation and tell you honestly if you're on track.

West Pharmaceutical Services (WST): +13%

The drug-delivery components maker beat expectations on both lines and raised its full-year guidance, with next quarter's outlook also coming in ahead of what analysts were modeling. Demand for high-value injectable components, especially those serving the biologics and GLP-1 markets, is running hotter than the Street expected.

Quest Diagnostics (DGX): +8%

The lab testing giant is climbing, and it isn't alone: healthcare names fill out much of today's gainers list. When an entire sector shows up in green at once, it says as much about where money is moving as about any single company.

Lockheed Martin (LMT): +5%

The defense giant beat expectations across the board for the second quarter and hiked its full-year earnings outlook. In a premarket where clean beats are getting shrugged off elsewhere, a beat-and-raise from a defense name is being rewarded, a signal that investors still trust where this spending cycle is headed.

Tesla (TSLA): -8%

The EV maker missed earnings expectations for the second quarter, with free cash flow turning negative as margins came under pressure. When the cash machine sputters at the same time profitability slips, the growth story gets harder to defend, and the market is repricing accordingly.

Alphabet (GOOGL): -5%

The Google parent raised its capital spending plans again, now expecting up to $205 billion this year to build out its AI capabilities. Investors keep asking when the AI buildout starts paying for itself, and every guidance hike pushes that answer further into the future.

Texas Instruments (TXN): -5%

The chipmaker beat the Street on both earnings and revenue, and the stock is falling anyway. Chip names are priced for perfection right now, and a clean beat apparently no longer clears the bar.

IBM (IBM): -2%

The legacy tech giant confirmed the bad news it previewed last week, reporting profit and revenue below expectations. That preliminary release already sparked the biggest sell-off in the stock's history, and the full report gave investors no reason to reconsider.

So why do most investors only think about them in April? DePaolo & May builds forward-looking tax, investment, and retirement strategies for serious portfolios. Answer a few questions and book a no-obligation call with a fiduciary advisor. 

Deckers Outdoor (DECK)

The HOKA and UGG parent reports earnings after the close tonight, and retail traders are circling a stock that has been beaten down this year and now trades well below analyst targets. The debate centers on whether HOKA's growth held up, since the running shoe brand has been carrying the entire story.

The Street is expecting a modest quarter, with earnings projected to decline from a year ago even as revenue grows. For a name this far below where analysts think it should trade, tonight's report could be the catalyst that finally moves it, in either direction.

✌️That’s it for today.